Rebetron

This page contains recent news articles, when available, and an overview of Rebetron but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Chimenti v. Kimber, No. 3:CV-01-0273 (MDPa. 02/13/2006)  -  Feb 13, 2006
The FDA granted approval for Rebetron treatment in May or June, 1998. However, Dr. Mohadjerin allegedly informed Chimenti that he still could not prescribe ... $2.95 - U.S. District Court, Middle District of... - VersusLaw

Dichiara v. Pataki, No. 1:06-cv-6123-ENV-LB (EDNY 03/07/2007)  -  Mar 7, 2007
As a result, his rebetron treatment was discontinued on March 20, 2005. On April 3, 2006, plaintiff was referred to Staten Island University Hospital for a ... $2.95 - U.S. District Court, Eastern District... - VersusLaw

Press Release: Schering-Plough Announces Global Agreement With …  -  Aug 14, 2006
REBETRON(TM) combination therapy, for the treatment ... REBETRON combination therapy represents a ... president of Schering Laboratories. ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Asthma combo as needed cuts steroid exposure.(Pulmonary …  -  Jul 1, 2007
REBETRON Combination Therapy was the subject of four additional ... activity and ... Prior to REBETRON combination therapy, the only drugs approved in the ... Pay-Per-View - Family Practice News - HighBeam Research

Press Release: Schering-Plough Reports Top-Line Results of the IDEAL ...  -  Jan 14, 2008
REBETRON Combination Therapy was the subject of four additional ... activity and ... Prior to REBETRON combination therapy, the only drugs approved in the ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Research and Markets: Stakeholder Insight: Asthma -- …  -  Mar 21, 2005
REBETRON Combination Therapy was the subject of four additional ... activity and ... Prior to REBETRON combination therapy, the only drugs approved in the ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Schering-Plough Announces Global Agreement With …  -  Aug 14, 2006
REBETRON(TM) combination therapy, for the treatment ... REBETRON combination therapy represents a ... president of Schering Laboratories. ... Pay-Per-View - PR Newswire Europe - HighBeam Research

United States 2nd Circuit Court of Appeals Reports - JOHNSON v. …  -  Jun 24, 2005
Johnson finally commenced Rebetron therapy in August 2000. B. Procedural History Johnson filed his original complaint, pro se, on March 13, 2001 and, ... Pay-Per-View - United States 2nd Circuit Court of... - Loislaw

Press Release: Schering-Plough Initiates PEGINTRON(R) Maintenance …  -  Jan 13, 2006
REBETRON Combination Therapy was the subject of four additional ... activity and ... Prior to REBETRON combination therapy, the only drugs approved in the ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Press Release: Schering-Plough Highlights PEGINTRON(TM) and …  -  Apr 17, 2008
REBETRON Combination Therapy was the subject of four additional ... activity and ... Prior to REBETRON combination therapy, the only drugs approved in the ... Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - MARTINEZ v. BAIRD (Ariz....  -  Aug 23, 2006
HCV is sometimes treated by administering Rebetron (a combination of ... In February 1999, Plaintiff requested Rebetron treatment for his HCV[fn3] (PSUD ¶ 5 ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Loislaw Federal District Court Opinions - CHIMENTI v. MOHADJERIN ( …  -  Jun 24, 2008
Approval of Rebetron treatment was announced by the FDA in May or June, 1998. Thereafter, the Center for Disease Control ("CDC") issued a national protocol ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Article: Late relapse a concern in tamoxifen/radiotherapy.(Women's …  -  Mar 15, 2005
Article: ICN Cites Schering-Plough Clinical Studies of Rebetron(TM) . ... REBETRON Combination Therapy was the subject of four additional ... activity and ... Pay-Per-View - Family Practice News - HighBeam Research

Martinez v. Baird, No. CV 03-1729-PHX-RCB (D.Ariz. 08/23/2006)  -  Aug 23, 2006
HCV is sometimes treated by administering Rebetron (a combination of Interferon ... In February 1999, Plaintiff requested Rebetron treatment for his HCV*fn3 ... $2.95 - U.S. District Court, District of Arizona - VersusLaw

Press Release: Results of PEG-INTRON(R) and REBETOL(R) Study in …  -  Oct 27, 2006
Weekly Dosing of PEG-INTRON Provides ... market REBETRON Combination Therapy in the ... REBETRON(TM) Combination Therapy, which contains ... market REBETRON ... Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - McKITRICK v. BARNHART (D. …  -  Apr 12, 2005
He twice tried Rebetron interferon, but it made him sick and did not ... At the time, he was undergoing Rebetron treatment, which made him extremely sleepy. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

McKitrick v. Barnhart, 364 F.Supp.2d 1272 (D.Kan. 04/12/2005)  -  Apr 12, 2005
He twice tried Rebetron interferon, but it made him sick and did not ... At the time, he was undergoing Rebetron treatment, which made him extremely sleepy. ... $2.95 - U.S. District Courts - VersusLaw

Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility...  -  Feb 27, 2005
Analysis of the registration trials of interferon and ribavirin (Rebetron) found the SVR was both higher and lower in Hispanic patients depending on the ... Nature.com

combination therapy | Definition of combination therapy | HighBeam.com...  -  Jul 12, 2006
PR Newswire; November 10, 1998 ; 700+ words ... ... effectiveness of REBETRON Combination Therapy in relapse patients ... monotherapy, REBETRON Combination ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research

DDW: Relapsed HCV Patients Achieve Sustained Response with 72- …  -  May 22, 2006
...with chronic hepatitis C who became refractory to Rebetron (pegylated interferon alfa 2a plus ribavirin), according to a pilot study reported here. ... MedPage Today

Alcoholic Liver Disease Treatment - Alcoholic Liver Disease Health …  -  Dec 12, 2008
Rebetron is the combination of interferon alpha-2b and ribavirin. Pegylated interferons (PegINF) are long-acting formulations of interferon. ... New York Times

Box 1 : Network pharmacology: the next paradigm in drug discovery : …  -  Oct 20, 2008
...combinations have now been reformulated in single multicomponent medicines, such as Atripla, Advair, Caduet, Combivir, Epzicom, Rebetron and Truvada. ... Nature.com

Wisconsin to get $4.4M of Schering-Plough settlement  -  Aug 31, 2006
According to government allegations, Schering-Plough bribed doctors to prescribe its hepatitis drugs PEG-Intron and Rebetron, and bladder-cancer medication ... Bizjournals.com

BC government failing to treat hep C epidemic: doctor  -  Jul 29, 2008
Anti-viral drugs such as Pegetron and Rebetron have a cure rate of between 45 per cent and 80 per cent, according to the BC Ministry of Health. ... CBC.ca

Loislaw Federal District Court Opinions - CONNERS v. SPECTRASITE …  -  Oct 12, 2006
Conners began receiving treatment for his Hepatitis C, consisting of a combination of the drugs Interferon and Rebetron, after his diagnosis in 1998. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Don't mix hepatitis B drug with interferon, Health Canada warns  -  Mar 12, 2008
...bacteria and other foreign substances — are marketed under brand names including Pegasys, Pegatron, Intron, Unitron Peg, Rebetron, Roferon A, Infergen, ... CBC.ca

Southwest Nebraska News - from the Republican Valley Media Group, …  -  Feb 9, 2007
Finally, Schering allegedly paid kickbacks to doctors to induce them to prescribe hepatitis drugs PEG-Intron and Rebetron and bladder cancer medication ... Southwest Nebraska News

St. Paul Pioneer Press : LIVER TESTS MANDATED TO AVOID SUDDEN …  -  Apr 13, 2005
...pravastatin (Pravachol), pyrazinamide (Tebrazid), ribavirin (Rebetol), ribavirin/ interferon alfa 2b (Rebetron), rifampin (Rifadin), riluzole (Rilutek), ... $2.95 - St. Paul Pioneer Press - NewsBank

RIBAVIRIN AND INTERFERON ALFA-2B (Oral route, Injection route) - rye …  -  May 1, 2007
Effective November 2004, Rebetron[R] was discontinued by the manufacturer. In deciding to use a medicine, the risks of taking the medicine must be weighed ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Doctors surprised by probe linking Singulair to suicide | Article...  -  Mar 28, 2008
Rebetron won FDA approval in the summer of 1998 ... healthcare information company. The FDA approval of Peg-Intron "is ... center at Hackensack University ... Pay-Per-View - The Record - HighBeam Research

The reason for those liver tests.  -  Mar 25, 2005
...piroxicam (Feldene), pravastatin (Pravachol), pyrazinamide (Tebrazid), ribavirin (Rebetol), ribavirin/interferon alfa 2b (Rebetron), rifampin (Rifadin), ... Free with registration - Sun Herald - AccessMyLibrary.com

[U] City of Philadelphia v. Workers' Compensation Appeal Board, No....  -  Oct 2, 2007
The medical reports detailed Brown's treatment with 48 weeks of Rebetron therapy in 2000, with a virologic relapse in late 2001, necessitating Peg-Intron ... $2.95 - Pennsylvania Commonwealth Court - VersusLaw

Hepatitis C and Your Digestive System  -  Mar 1, 2006
A combination form of these drugs is also available, called Rebetron. More recently, another form of interferon -- peginterferon, or pegylated interferon ... WebMD

Press Release: European Union's CHMP Issues Positive Opinion on …  -  Sep 24, 2007
The approval ... in all 15 European Union-Member States ... market in the European Union, where they ... REBETRON(TM) Combination Therapy containing ... ... Pay-Per-View - PR Newswire - HighBeam Research

Salahuddin v. Goord, 467 F.3d 263 (2d Cir. 10/27/2006)  -  Oct 27, 2006
...the delay in the prescription and approval of Rebetron medication, and the choice of Rebetron, with its nationwide waiting list, rather than another ... $2.95 - U.S. Court of Appeals, Second Circuit - VersusLaw

For HCV Genotype 2 or 3, 12 Weeks' Treatment, Rather Than 24 ...  -  Jun 22, 2005
...without adversely affecting outcomes," the authors conclude. One of the authors reports financial arrangements with Schering-Plough, maker of Rebetron. Medscape

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison...  -  Oct 12, 2005
Inmates received Rebetron combination therapy containing Rebetol (ribavirin) capsules and Intron A (interferon alfa-2b, recombinant), and duration was based ... RedOrbit

Toxin may put sting on brain tumors | Article from Deseret News (Salt...  -  Jul 30, 2006
2001, seeking documents about pricing and marketing practices for hepatitis drugs Intron A and Rebetron, and Temodar for brain tumors. ... Pay-Per-View - Deseret News - HighBeam Research

Loislaw Federal District Court Opinions - DOYLE v. ASTRUE (WDPa. 4-2-...  -  Apr 2, 2008
In April 2001, after Mr. Doyle continued to complain of fatigue, gastric reflux and insomnia, Dr. Amin began a second period of treatment with Rebetron, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Article: FDA Grants Priority Review for Schering-Plough's Peginterfero...  -  Feb 1, 2008
PEG-INTRON (peginterferon alfa-2b) Powder for Injection; and REBETRON Combination Therapy containing REBETOL (ribavirin, USP) Capsules ... ... Pay-Per-View - BIOTECH Patent News - HighBeam Research

Southern Illinoisan : Lifestyles<br>  -  Sep 20, 2005
...pentamidine (Pentam), pioglitazone (Actos), piroxicam (Feldene), pribavirin/interferon alfa 2b (Rebetron), rifampin (Rifadin), sulindac (Clinoril), ... $2.95 - Southern Illinoisan - NewsBank

Press Release: Positive results from Visudyne(R) combination therapy ...  -  Mar 28, 2008
INTRON A/REBETOL group. In many but ... INTRON/REBETOL groups than in the INTRON ... REBETRON(TM) Combination Therapy, which contains ... ... Pay-Per-View - PR Newswire - HighBeam Research

干扰素市场分�?  -  Sep 5, 2006
...制�?，先�?�葆雅公�?�获得授让�?�，加快了商�?化的开拓进程，1985年以商�?�??Intron A 在爱尔兰�?�?�律宾等国上市，1986 年6月获FDA批准�?�在美国上市，商�?�??Rebetron。 ... 金�?界

GlobeImmune Announces Management Appointments.  -  Jan 5, 2005
...in the Department of Hepatology/Gastroenterology at Schering Plough where he was medical lead on the pediatric sNDA for Rebetron for chronic HCV. ... $4.95 - PR Newswire - ECNext

After the attack, his wounds are exposed: Called a hero for his...  -  Jul 24, 2006
In September 2000, he was admitted into a clinical trial for a therapy called Rebetron, which included three-times-a-week injections of the drug interferon. ... Free with registration - Milwaukee Journal Sentinel - AccessMyLibrary.com

Loislaw Federal District Court Opinions - COWSER v. AMERICAN …  -  Jul 6, 2005
Mr. Cowser was undergoing treatment for Hepatitis C for which he was prescribed Rebetron, which includes ribavirin pills and interferon injections. 13. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Southern Illinoisan : Lifestyles<br>  -  Mar 29, 2005
...piroxicam (Feldene), pravastatin (Pravachol), pyrazinamide (Tebrazid), ribavirin (Rebetol), ribavirin/interferon alfa 2b (Rebetron), rifampin (Rifadin), ... $2.95 - Southern Illinoisan - NewsBank

Press Release: GlobeImmune Announces Management Appointments. - …  -  Jan 5, 2005
...in the Department of Hepatology/Gastroenterology at Schering Plough where he was medical lead on the pediatric sNDA for Rebetron for chronic HCV. ... Pay-Per-View - PR Newswire - HighBeam Research

UTAH JOINS $435 MILLION SETTLEMENT WITH DRUG …  -  Sep 1, 2006
The company's illegal payments to physicians to induce them to prescribe hepatitis drugs PEG-Intron and Rebetron and bladder cancer medication Intron-A. ... Pay-Per-View - US Fed News - Factiva, from Dow Jones

STARK CONSEQUENCES; A SAILOR'S STORY; Called a hero for his …  -  Jul 24, 2006
In September 2000, he was admitted into a clinical trial for a therapy called Rebetron, which included three-times-a-week injections of the drug interferon. ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research

Article: Bayer to exhibit rude health. - Sunday Business (London) | …  -  Aug 27, 2006
In the United States, Schering-Plough markets REBETRON ... synthetic nucleoside analog. Schering-Plough has exclusive rights ... ... Pay-Per-View - Sunday Business - HighBeam Research

Article: EU STANDARDISATION BODY WELCOMES NEW ROMANIA …  -  Jan 7, 2006
...the company's Eastern European business, its North American specialty pharmaceutical business and its Rebetron hepatitis C royalty stream. "We agree ... ... Pay-Per-View - European Report - HighBeam Research

Press of Atlantic City, The : QUESTION & ANSWER FROM THE …  -  Mar 28, 2005
...piroxicam (Feldene), pravastatin (Pravachol), pyrazinamide (Tebrazid), ribavirin (Rebetol), ribavirin/interferon alfa 2b (Rebetron), rifampin (Rifadin), ... $2.95 - Press of Atlantic City, The - NewsBank

Handbook of Kidney Transplantation.(Handbook of Kidney …  -  Jul 1, 2005
Nephrology Nursing Journal; February 1, 2003 ; 700+ words ... ... a course of rebetron and ribavirin and was cleared for renal transplant. ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

Margaret Chan, MD, elected Director-General of World Health …  -  Dec 1, 2006
Article: Schering-Plough receives FDA approval to market Rebetron ... Transplant News; December 17, 1998 ; 692 words ... ... general population is ... Pay-Per-View - Transplant News - HighBeam Research

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.